May 22, 2019 09:53 AM EDTUpdated May 23, 06:58 AM
Pharma

An­oth­er Eli Lil­ly on­col­o­gy drug is in trou­ble, as Japan is­sues Verzenio safe­ty warn­ing

Natalie Grover

Reporter

Eli Lil­ly is in trou­ble, again. This year, a late-stage fail­ure prompt­ed the with­draw­al of its can­cer drug Lartru­vo; its erec­tile dys­func­tion treat­ment Cialis …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump an­nounces picks for FDA, CDC; No­var­tis seeks bolt-on deals, rais­es guid­ance; RFK Jr., Elon Musk may find ...

For CDC, Trump picks Dave Wel­don, a for­mer con­gress­man who pushed for vac­cine in­jury claims

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Sanofi in­tro­duces new 340B pay­ment mod­el — re­port

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times